Fri 20'th Oct 2017
Endocyte Stock Analysis
Technical stock analysis for Fri 20'th Oct 2017
Buy candidate since 2017-10-16 Gain 20.56%
Endocyte lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 123.16% during the next 3 months and, with 90% probability hold a price between $8.15 and $15.17 at the end of this period.
Only positive signals in the chart today. Endocyte holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $4.70 and $2.95. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday October 16, 2017, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
* Golden Star Signal* is when the short-term moving average, the long-term moving average, and priceline meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Relative Strength Index (RSI)
RSI14 is 65 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $4.91 and $4.83. On the upside the stock meets some resistance from accumulated volume at $5.70, $5.88 and $6.10.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Endocyte finds support just below today's level at $4.91. If this is broken, then the next support from accumulated volume will be at $4.83 and $4.34.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.31 between high and low, or 6.33%. For the last week, the stock has had a daily average volatility of 7.86%.
Our recommended stoploss: $5.00 (-3.70%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 4 days ago.)
Very Low Low Medium High Very High
Endocyte holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Buy ECYT CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).